Phase II study of a combination of TS-1 and TXL for advanced/recurrent gastric cancer patients with peritoneal metastasis
Not Applicable
- Conditions
- Patients with gastric cancer and peritoneal metastasis
- Registration Number
- JPRN-UMIN000000746
- Lead Sponsor
- OGSG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.with severe cavity fluid which needs drainage 2.with a central nerve symptoms 3.with fresh intestinal beeding 4.with active double cancers 5.with an allergic reaction against TS-1 or TXL 6.with severe allergy against medicine 7.with severe diseases (cardiac failure, arrhythmia, renal dysfunction, liver dysfunction, interstitial pneumonia, severe neural disorder, uncontrolled DM, intestinal obstruction, etc.) 8.under pregnancy or nursing 9.doctors' decision not to register
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method